04/30/2024
3:20 PM | Alpine Immune Sciences (Subject)
Decheng Capital China Life Sciences USD Fund III, L.P. (Filed by)
| Form SC 13D/A | |
04/29/2024
5:08 PM | Alpine Immune Sciences (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
04/25/2024
6:48 PM | Alpine Immune Sciences (Filer)
| Form 10-K/A | |
04/22/2024
3:27 PM | Alpine Immune Sciences (Subject)
| Form SC 14D9 | |
04/22/2024
3:15 PM | Alpine Immune Sciences (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC TO-T | |
04/11/2024
3:08 PM | Alpine Immune Sciences (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC TO-C | |
04/10/2024
4:22 PM | Alpine Immune Sciences (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC TO-C | |
|
04/10/2024
4:27 PM | Alpine Immune Sciences (Subject)
| Form SC14D9C | |
04/10/2024
4:10 PM | Alpine Immune Sciences (Subject)
| Form SC14D9C | |
04/10/2024
3:26 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
6:11 PM | Alpine Immune Sciences (Issuer)
FUHS ULRICH MARTIN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2024
3:31 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
7:04 AM | Alpine Immune Sciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2024
7:05 AM | Alpine Immune Sciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
11:29 AM | Alpine Immune Sciences (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024
3:43 PM | Alpine Immune Sciences (Subject)
Omega Fund VI, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
3:36 PM | Alpine Immune Sciences (Subject)
GREAT POINT PARTNERS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
8:22 AM | Alpine Immune Sciences (Subject)
Lynx1 Capital Management LP (Filed by)
| Form SC 13G/A | |
01/29/2024
6:04 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:54 PM | Alpine Immune Sciences (Issuer)
Decheng Capital China Life Sciences USD Fund III, L.P. (Reporting)
Decheng Capital Management III , LLC (0001747821) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:48 PM | Alpine Immune Sciences (Issuer)
Cui Xiangmin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:36 PM | Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
3:39 PM | Alpine Immune Sciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:06 PM | Alpine Immune Sciences (Issuer)
DURAND REMY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:07 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:08 PM | Alpine Immune Sciences (Issuer)
PENG STANFORD L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
5:08 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:45 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:01 PM | Alpine Immune Sciences (Issuer)
Peetz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:02 PM | Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:03 PM | Alpine Immune Sciences (Issuer)
Cui Xiangmin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:03 PM | Alpine Immune Sciences (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:05 PM | Alpine Immune Sciences (Issuer)
Drappa Jorn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:06 PM | Alpine Immune Sciences (Issuer)
Hernday Natasha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:07 PM | Alpine Immune Sciences (Issuer)
CONWAY ROBERT E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
6:32 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:20 PM | Alpine Immune Sciences (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
3:16 PM | Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/29/2023
3:18 PM | Alpine Immune Sciences (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
8:07 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
4:00 PM | Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
12/27/2023
4:02 PM | Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/21/2023
6:35 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
6:34 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
3:23 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
6:50 PM | Alpine Immune Sciences (Subject)
GOLD MITCHELL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
8:20 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
3:33 PM | Alpine Immune Sciences (Subject)
Rickey James Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
3:36 PM | Alpine Immune Sciences (Subject)
Rickey James Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
4:30 PM | Alpine Immune Sciences (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
8:02 PM | Alpine Immune Sciences (Issuer)
GOLD MITCHELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
8:00 PM | Alpine Immune Sciences (Subject)
GOLD MITCHELL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
6:31 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:00 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
9:25 AM | Alpine Immune Sciences (Subject)
Frazier Life Sciences VIII, L.P. (Filed by)
| Form SC 13D/A | |
11/14/2023
3:16 PM | Alpine Immune Sciences (Subject)
Decheng Capital China Life Sciences USD Fund III, L.P. (Filed by)
| Form SC 13D/A | |
11/13/2023
8:15 PM | Alpine Immune Sciences (Subject)
Alpine ImmunoSciences, L.P. (Filed by)
| Form SC 13D/A | |
11/13/2023
7:51 AM | Alpine Immune Sciences (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
11/08/2023
4:20 PM | Alpine Immune Sciences (Issuer)
Rickey James Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
7:18 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
8:37 PM | Alpine Immune Sciences (Subject)
| Form FWP | |
11/06/2023
3:20 PM | Alpine Immune Sciences (Subject)
Rickey James Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
5:02 AM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
5:05 AM | Alpine Immune Sciences (Filer)
| Form 424B5 | |
11/02/2023
8:12 AM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
3:02 PM | Alpine Immune Sciences (Subject)
Cormorant Asset Management, LP (Filed by)
| Form SC 13G | |
10/04/2023
4:11 PM | Alpine Immune Sciences (Issuer)
Dummer Wolfgang (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2023
4:14 PM | Alpine Immune Sciences (Issuer)
Dummer Wolfgang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
11:15 PM | Alpine Immune Sciences (Filer)
| Form EFFECT | |
08/14/2023
3:18 PM | Alpine Immune Sciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023
3:22 PM | Alpine Immune Sciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
11:15 PM | Alpine Immune Sciences (Filer)
| Form EFFECT | |
